Related Experiment Videos
Computer software for testing drug susceptibility of malaria parasites
P P Reinders1, P H van Vianen, M van der Keur
1Department of Cytochemistry and Cytometry, Medical Faculty, University of Leiden, The Netherlands.
Cytometry
|March 1, 1995
Summary
A new computer program automates flow cytometry data analysis for antimalarial drug susceptibility testing. This tool accurately assesses drug efficacy by analyzing malaria-infected red blood cells, improving drug discovery efforts.
Area of Science:
- Parasitology
- Medical Technology
- Computational Biology
Background:
- In vitro antimalarial drug susceptibility testing is crucial for malaria control.
- Flow cytometry offers a high-throughput method for analyzing cellular responses.
Purpose of the Study:
- To develop and validate a computer program for automated analysis of flow cytometry data in antimalarial drug susceptibility testing.
Main Methods:
- Malaria-infected red blood cells (RBCs) were cultured with varying antimalarial drug concentrations.
- Cells were stained with Hoechst dye, and fluorescence intensity correlated with parasite DNA content and developmental stage.
- Data were acquired using a FACStar flow cytometer, generating FCS 1.0 files.
- The HP PAS-CAL program was developed to identify cell populations and quantify parasite load.
Main Results:
- The HP PAS-CAL program successfully identified five distinct cell populations: uninfected RBCs, infected RBCs, free parasites, leukocytes, and debris.
- The program calculated key metrics including the percentage of infected cells, total parasite nuclei, and average nuclei per parasite.
- Drug dose-response curves were generated, and the automated analysis demonstrated high accuracy (>99%) across 862 drug tests.
Conclusions:
- The automated HP PAS-CAL program provides a robust and efficient method for analyzing flow cytometry data in antimalarial drug susceptibility testing.
- This tool streamlines the process, reduces user interaction, and flags potential analysis issues, facilitating reliable drug efficacy assessment.